nodes	percent_of_prediction	percent_of_DWPC	metapath
Lumiracoxib—PTGS1—breast cancer	0.28	0.636	CbGaD
Lumiracoxib—PTGS2—breast cancer	0.16	0.364	CbGaD
Lumiracoxib—UGT1A9—Irinotecan—breast cancer	0.0773	0.18	CbGbCtD
Lumiracoxib—CYP1A2—Anastrozole—breast cancer	0.0559	0.13	CbGbCtD
Lumiracoxib—CYP1A2—Toremifene—breast cancer	0.0511	0.119	CbGbCtD
Lumiracoxib—CYP2C9—Anastrozole—breast cancer	0.0504	0.117	CbGbCtD
Lumiracoxib—CYP2C19—Lapatinib—breast cancer	0.0404	0.0942	CbGbCtD
Lumiracoxib—CYP2C9—Idarubicin—breast cancer	0.0382	0.0889	CbGbCtD
Lumiracoxib—CYP2C9—Capecitabine—breast cancer	0.0209	0.0487	CbGbCtD
Lumiracoxib—CYP2C19—Tamoxifen—breast cancer	0.0202	0.0472	CbGbCtD
Lumiracoxib—CYP1A2—Tamoxifen—breast cancer	0.0187	0.0435	CbGbCtD
Lumiracoxib—CYP2C9—Tamoxifen—breast cancer	0.0168	0.0392	CbGbCtD
Lumiracoxib—CYP1A2—Fluorouracil—breast cancer	0.0138	0.0321	CbGbCtD
Lumiracoxib—CYP2C9—Paclitaxel—breast cancer	0.0131	0.0305	CbGbCtD
Lumiracoxib—CYP2C9—Fluorouracil—breast cancer	0.0124	0.0289	CbGbCtD
Lumiracoxib—Tolmetin—CXCL8—breast cancer	0.000799	0.149	CrCbGaD
Lumiracoxib—Bromfenac—PTGS1—breast cancer	0.000606	0.113	CrCbGaD
Lumiracoxib—Diclofenac—ABCC1—breast cancer	0.000497	0.0927	CrCbGaD
Lumiracoxib—Diclofenac—CXCL8—breast cancer	0.00044	0.082	CrCbGaD
Lumiracoxib—Tolmetin—PTGS1—breast cancer	0.000408	0.076	CrCbGaD
Lumiracoxib—Meclofenamic acid—PTGS1—breast cancer	0.000402	0.0749	CrCbGaD
Lumiracoxib—Bromfenac—PTGS2—breast cancer	0.000347	0.0646	CrCbGaD
Lumiracoxib—Mefenamic acid—PTGS1—breast cancer	0.000312	0.0582	CrCbGaD
Lumiracoxib—Tolmetin—PTGS2—breast cancer	0.000233	0.0434	CrCbGaD
Lumiracoxib—Meclofenamic acid—PTGS2—breast cancer	0.00023	0.0428	CrCbGaD
Lumiracoxib—Diclofenac—PTGS1—breast cancer	0.000224	0.0418	CrCbGaD
Lumiracoxib—Diclofenac—CYP1A1—breast cancer	0.000205	0.0383	CrCbGaD
Lumiracoxib—Mefenamic acid—PTGS2—breast cancer	0.000179	0.0333	CrCbGaD
Lumiracoxib—Diclofenac—CYP3A4—breast cancer	0.000131	0.0244	CrCbGaD
Lumiracoxib—Diclofenac—PTGS2—breast cancer	0.000128	0.0239	CrCbGaD
Lumiracoxib—Diclofenac—ALB—breast cancer	0.000114	0.0213	CrCbGaD
Lumiracoxib—Diclofenac—ABCB1—breast cancer	0.000109	0.0203	CrCbGaD
Lumiracoxib—UGT1A9—endocrine gland—breast cancer	1.07e-05	0.082	CbGeAlD
Lumiracoxib—CYP2C9—mammary gland—breast cancer	8.82e-06	0.0675	CbGeAlD
Lumiracoxib—PTGS2—Disease—H2AFX—breast cancer	8.17e-06	6.52e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—GSTA1—breast cancer	8.13e-06	6.49e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—IDH1—breast cancer	8.13e-06	6.49e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—ALDOA—breast cancer	8.12e-06	6.48e-05	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PIK3CG—breast cancer	8.05e-06	6.42e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—NAT2—breast cancer	8.04e-06	6.42e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—GSTT1—breast cancer	8e-06	6.38e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—ACHE—breast cancer	8e-06	6.38e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—NCOA3—breast cancer	7.88e-06	6.29e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—ERCC2—breast cancer	7.88e-06	6.29e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—SLC2A2—breast cancer	7.83e-06	6.25e-05	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—MTHFR—breast cancer	7.81e-06	6.23e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	7.75e-06	6.18e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	7.75e-06	6.18e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—ERBB3—breast cancer	7.7e-06	6.15e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—FGFR2—breast cancer	7.69e-06	6.14e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—nipple—breast cancer	7.69e-06	0.0588	CbGeAlD
Lumiracoxib—PTGS2—Metabolism—COMT—breast cancer	7.67e-06	6.12e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CPT1A—breast cancer	7.67e-06	6.12e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—MTR—breast cancer	7.67e-06	6.12e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—ABCG2—breast cancer	7.67e-06	6.12e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—GSTP1—breast cancer	7.64e-06	6.09e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—CYP17A1—breast cancer	7.57e-06	6.04e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—HMOX1—breast cancer	7.53e-06	6.01e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—HPGDS—breast cancer	7.52e-06	6e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—ITPR1—breast cancer	7.51e-06	6e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PTGS1—breast cancer	7.5e-06	5.98e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—ENO1—breast cancer	7.5e-06	5.98e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—HBA1—breast cancer	7.47e-06	5.96e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	7.47e-06	5.96e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—MTHFR—breast cancer	7.4e-06	5.91e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—TERT—breast cancer	7.38e-06	5.89e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—ALB—breast cancer	7.37e-06	5.88e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—CYP2D6—breast cancer	7.35e-06	5.87e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—GSTT1—breast cancer	7.3e-06	5.82e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—ACHE—breast cancer	7.3e-06	5.82e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—breast cancer	7.27e-06	5.8e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—ABCB1—breast cancer	7.23e-06	5.77e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—NCOA2—breast cancer	7.22e-06	5.76e-05	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—CAV1—breast cancer	7.21e-06	5.75e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—FGFR1—breast cancer	7.17e-06	5.72e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—TYMS—breast cancer	7.1e-06	5.66e-05	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PIK3CD—breast cancer	7.08e-06	5.65e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—HIF1A—breast cancer	7.06e-06	5.63e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—MED12—breast cancer	7.05e-06	5.63e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—DPYD—breast cancer	7.05e-06	5.63e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—GSTM1—breast cancer	7.02e-06	5.6e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—NCOR1—breast cancer	7.02e-06	5.6e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PLA2G4A—breast cancer	7.02e-06	5.6e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—FASN—breast cancer	7e-06	5.58e-05	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—ALB—breast cancer	6.99e-06	5.58e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—BCHE—breast cancer	6.97e-06	5.56e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—ALDOA—breast cancer	6.94e-06	5.54e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CYP17A1—breast cancer	6.91e-06	5.51e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—SLC5A5—breast cancer	6.88e-06	5.49e-05	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	6.88e-06	5.49e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—ENO1—breast cancer	6.84e-06	5.45e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PTGS1—breast cancer	6.84e-06	5.45e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CAV1—breast cancer	6.83e-06	5.45e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	6.81e-06	5.43e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—NCOA3—breast cancer	6.74e-06	5.38e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—ALB—breast cancer	6.72e-06	5.36e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—GPX1—breast cancer	6.72e-06	5.36e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CYP2D6—breast cancer	6.7e-06	5.35e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—SLC2A2—breast cancer	6.69e-06	5.34e-05	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—NOS3—breast cancer	6.68e-06	5.33e-05	CbGpPWpGaD
Lumiracoxib—PTGS1—nipple—breast cancer	6.66e-06	0.051	CbGeAlD
Lumiracoxib—PTGS2—Metabolism—CYP1A1—breast cancer	6.65e-06	5.31e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—SLC2A1—breast cancer	6.65e-06	5.31e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—NQO1—breast cancer	6.65e-06	5.31e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	6.62e-06	5.28e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—ERCC2—breast cancer	6.6e-06	5.26e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—NCOA2—breast cancer	6.58e-06	5.25e-05	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PIK3CG—breast cancer	6.56e-06	5.24e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—ABCG2—breast cancer	6.55e-06	5.23e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—CPT1A—breast cancer	6.55e-06	5.23e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—MTR—breast cancer	6.55e-06	5.23e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	6.51e-06	5.2e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—CYP3A4—breast cancer	6.48e-06	5.17e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	6.45e-06	5.15e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—HPGDS—breast cancer	6.43e-06	5.13e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—NOS2—breast cancer	6.42e-06	5.13e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—HBA1—breast cancer	6.39e-06	5.1e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—FASN—breast cancer	6.38e-06	5.09e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—CYP1B1—breast cancer	6.37e-06	5.09e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—NOTCH1—breast cancer	6.36e-06	5.08e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—BCHE—breast cancer	6.36e-06	5.07e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—SLC5A5—breast cancer	6.28e-06	5.01e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—HSP90AA1—breast cancer	6.25e-06	4.99e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—ACHE—breast cancer	6.23e-06	4.97e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—GSTT1—breast cancer	6.23e-06	4.97e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—KIT—breast cancer	6.22e-06	4.96e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—APC—breast cancer	6.22e-06	4.96e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—MTHFR—breast cancer	6.2e-06	4.95e-05	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PIK3CB—breast cancer	6.17e-06	4.92e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—EGF—breast cancer	6.15e-06	4.91e-05	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PTGS2—breast cancer	6.11e-06	4.88e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—NCOA1—breast cancer	6.08e-06	4.85e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—NQO1—breast cancer	6.06e-06	4.84e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—SLC2A1—breast cancer	6.06e-06	4.84e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—STK11—breast cancer	5.99e-06	4.78e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—CYP19A1—breast cancer	5.99e-06	4.78e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	5.94e-06	4.74e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CYP3A4—breast cancer	5.91e-06	4.72e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—CYP17A1—breast cancer	5.9e-06	4.71e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	5.88e-06	4.69e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—BRAF—breast cancer	5.85e-06	4.67e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—ENO1—breast cancer	5.84e-06	4.66e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PTGS1—breast cancer	5.84e-06	4.66e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	5.82e-06	4.64e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CYP1B1—breast cancer	5.81e-06	4.64e-05	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PIK3CD—breast cancer	5.77e-06	4.6e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	5.75e-06	4.58e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—CYP2D6—breast cancer	5.73e-06	4.57e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—CAV1—breast cancer	5.72e-06	4.56e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—HSP90AA1—breast cancer	5.7e-06	4.55e-05	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—ALB—breast cancer	5.7e-06	4.54e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—AKT2—breast cancer	5.69e-06	4.54e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—breast cancer	5.63e-06	4.49e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—NCOA2—breast cancer	5.62e-06	4.49e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—COMT—breast cancer	5.57e-06	4.45e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—GSTP1—breast cancer	5.55e-06	4.43e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—NCOA1—breast cancer	5.54e-06	4.42e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—PIK3CD—breast cancer	5.47e-06	4.36e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—HMOX1—breast cancer	5.47e-06	4.36e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—STK11—breast cancer	5.46e-06	4.36e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CYP19A1—breast cancer	5.46e-06	4.36e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	5.46e-06	4.36e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—ITPR1—breast cancer	5.46e-06	4.35e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—FASN—breast cancer	5.45e-06	4.35e-05	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—NOS3—breast cancer	5.45e-06	4.35e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—BCHE—breast cancer	5.43e-06	4.33e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—SERPINE1—breast cancer	5.41e-06	4.32e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—SLC5A5—breast cancer	5.36e-06	4.28e-05	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PTEN—breast cancer	5.33e-06	4.25e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—embryo—breast cancer	5.25e-06	0.0402	CbGeAlD
Lumiracoxib—CYP2C19—Metabolism—ABCB1—breast cancer	5.25e-06	4.19e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PIK3CG—breast cancer	5.21e-06	4.16e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—NQO1—breast cancer	5.18e-06	4.13e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—SLC2A1—breast cancer	5.18e-06	4.13e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—NOS3—breast cancer	5.16e-06	4.12e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—TYMS—breast cancer	5.16e-06	4.11e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	5.13e-06	4.09e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—NCOR1—breast cancer	5.1e-06	4.07e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PLA2G4A—breast cancer	5.1e-06	4.07e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—GSTM1—breast cancer	5.1e-06	4.07e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—COMT—breast cancer	5.08e-06	4.05e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	5.07e-06	4.05e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—GSTP1—breast cancer	5.06e-06	4.03e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—CYP3A4—breast cancer	5.05e-06	4.03e-05	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PIK3CB—breast cancer	5.03e-06	4.01e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	5.03e-06	4.01e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—HMOX1—breast cancer	4.99e-06	3.98e-05	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PTGS2—breast cancer	4.98e-06	3.98e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—ITPR1—breast cancer	4.98e-06	3.97e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—CYP1B1—breast cancer	4.97e-06	3.96e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—MDM2—breast cancer	4.9e-06	3.91e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—RAF1—breast cancer	4.88e-06	3.9e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—GPX1—breast cancer	4.88e-06	3.89e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—HSP90AA1—breast cancer	4.87e-06	3.89e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—CYP1A1—breast cancer	4.83e-06	3.85e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—ERBB2—breast cancer	4.83e-06	3.85e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—ERCC2—breast cancer	4.79e-06	3.82e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—ABCB1—breast cancer	4.79e-06	3.82e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—MTOR—breast cancer	4.77e-06	3.8e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—PIK3CB—breast cancer	4.77e-06	3.8e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CD4—breast cancer	4.76e-06	3.8e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—NCOA1—breast cancer	4.74e-06	3.78e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—TYMS—breast cancer	4.7e-06	3.75e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—CYP19A1—breast cancer	4.67e-06	3.73e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—STK11—breast cancer	4.67e-06	3.73e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—NCOR1—breast cancer	4.65e-06	3.71e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—GSTM1—breast cancer	4.65e-06	3.71e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PLA2G4A—breast cancer	4.65e-06	3.71e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PIK3CD—breast cancer	4.58e-06	3.65e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—ALB—breast cancer	4.52e-06	3.61e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—MTHFR—breast cancer	4.5e-06	3.59e-05	CbGpPWpGaD
Lumiracoxib—PTGS1—epithelium—breast cancer	4.48e-06	0.0343	CbGeAlD
Lumiracoxib—PTGS2—Disease—CDKN1B—breast cancer	4.47e-06	3.57e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—GPX1—breast cancer	4.45e-06	3.55e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CYP1A1—breast cancer	4.41e-06	3.51e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	4.38e-06	3.5e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—ERCC2—breast cancer	4.37e-06	3.49e-05	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PTEN—breast cancer	4.35e-06	3.47e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—COMT—breast cancer	4.34e-06	3.46e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—NOS3—breast cancer	4.33e-06	3.45e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—GSTP1—breast cancer	4.32e-06	3.45e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—epithelium—breast cancer	4.29e-06	0.0328	CbGeAlD
Lumiracoxib—PTGS1—skin of body—breast cancer	4.27e-06	0.0326	CbGeAlD
Lumiracoxib—CYP1A2—Metabolism—HMOX1—breast cancer	4.26e-06	3.4e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—ITPR1—breast cancer	4.25e-06	3.39e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CTNNB1—breast cancer	4.23e-06	3.37e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—CAV1—breast cancer	4.15e-06	3.31e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—CDKN1A—breast cancer	4.13e-06	3.29e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—PTEN—breast cancer	4.12e-06	3.29e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—MTHFR—breast cancer	4.11e-06	3.28e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—ABCB1—breast cancer	4.09e-06	3.26e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—skin of body—breast cancer	4.08e-06	0.0312	CbGeAlD
Lumiracoxib—PTGS1—endometrium—breast cancer	4.02e-06	0.0308	CbGeAlD
Lumiracoxib—CYP1A2—Metabolism—TYMS—breast cancer	4.02e-06	3.21e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PIK3CB—breast cancer	3.99e-06	3.19e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—endocrine gland—breast cancer	3.98e-06	0.0305	CbGeAlD
Lumiracoxib—CYP1A2—Metabolism—GSTM1—breast cancer	3.97e-06	3.17e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PLA2G4A—breast cancer	3.97e-06	3.17e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—NCOR1—breast cancer	3.97e-06	3.17e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	3.97e-06	3.17e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—endometrium—breast cancer	3.84e-06	0.0294	CbGeAlD
Lumiracoxib—PTGS2—Disease—SRC—breast cancer	3.82e-06	3.05e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—GPX1—breast cancer	3.8e-06	3.03e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—CAV1—breast cancer	3.79e-06	3.02e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PIK3CG—breast cancer	3.78e-06	3.02e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—CYP1A1—breast cancer	3.76e-06	3e-05	CbGpPWpGaD
Lumiracoxib—UGT1A9—Metabolism—PIK3CA—breast cancer	3.76e-06	3e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—ERCC2—breast cancer	3.73e-06	2.98e-05	CbGpPWpGaD
Lumiracoxib—PTGS1—uterus—breast cancer	3.71e-06	0.0284	CbGeAlD
Lumiracoxib—PTGS2—Disease—STAT3—breast cancer	3.68e-06	2.94e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—female reproductive system—breast cancer	3.65e-06	0.0279	CbGeAlD
Lumiracoxib—PTGS1—pituitary gland—breast cancer	3.64e-06	0.0278	CbGeAlD
Lumiracoxib—PTGS1—adipose tissue—breast cancer	3.62e-06	0.0277	CbGeAlD
Lumiracoxib—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	3.62e-06	2.89e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—uterus—breast cancer	3.54e-06	0.0271	CbGeAlD
Lumiracoxib—PTGS2—Disease—MAPK3—breast cancer	3.52e-06	2.81e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—MTHFR—breast cancer	3.51e-06	2.8e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—pituitary gland—breast cancer	3.48e-06	0.0266	CbGeAlD
Lumiracoxib—PTGS2—adipose tissue—breast cancer	3.46e-06	0.0265	CbGeAlD
Lumiracoxib—CYP2C9—Metabolism—PIK3CG—breast cancer	3.45e-06	2.75e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PTEN—breast cancer	3.45e-06	2.75e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—MYC—breast cancer	3.42e-06	2.73e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—TGFB1—breast cancer	3.41e-06	2.72e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—EGFR—breast cancer	3.35e-06	2.67e-05	CbGpPWpGaD
Lumiracoxib—PTGS1—female reproductive system—breast cancer	3.33e-06	0.0255	CbGeAlD
Lumiracoxib—CYP2C19—Metabolism—PIK3CD—breast cancer	3.33e-06	2.65e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—ALB—breast cancer	3.28e-06	2.62e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—endocrine gland—breast cancer	3.25e-06	0.0249	CbGeAlD
Lumiracoxib—PTGS1—adrenal gland—breast cancer	3.25e-06	0.0249	CbGeAlD
Lumiracoxib—CYP1A2—Metabolism—CAV1—breast cancer	3.24e-06	2.58e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—female reproductive system—breast cancer	3.18e-06	0.0244	CbGeAlD
Lumiracoxib—PTGS2—Disease—KRAS—breast cancer	3.16e-06	2.52e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—NOS3—breast cancer	3.14e-06	2.51e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—adrenal gland—breast cancer	3.11e-06	0.0238	CbGeAlD
Lumiracoxib—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	3.09e-06	2.47e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—endocrine gland—breast cancer	3.09e-06	0.0236	CbGeAlD
Lumiracoxib—UGT1A9—Metabolism—AKT1—breast cancer	3.07e-06	2.45e-05	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—PIK3CA—breast cancer	3.07e-06	2.45e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PIK3CD—breast cancer	3.03e-06	2.42e-05	CbGpPWpGaD
Lumiracoxib—PTGS1—female gonad—breast cancer	3.03e-06	0.0232	CbGeAlD
Lumiracoxib—PTGS2—bone marrow—breast cancer	3.01e-06	0.023	CbGeAlD
Lumiracoxib—CYP2C9—Metabolism—ALB—breast cancer	2.99e-06	2.39e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PIK3CG—breast cancer	2.95e-06	2.35e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—PIK3CA—breast cancer	2.91e-06	2.32e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PIK3CB—breast cancer	2.9e-06	2.31e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—female gonad—breast cancer	2.9e-06	0.0222	CbGeAlD
Lumiracoxib—CYP2C19—Metabolism—PTGS2—breast cancer	2.87e-06	2.29e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—NOS3—breast cancer	2.86e-06	2.29e-05	CbGpPWpGaD
Lumiracoxib—PTGS1—endocrine gland—breast cancer	2.82e-06	0.0216	CbGeAlD
Lumiracoxib—PTGS2—endocrine gland—breast cancer	2.69e-06	0.0206	CbGeAlD
Lumiracoxib—PTGS2—Disease—HRAS—breast cancer	2.69e-06	2.15e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PIK3CB—breast cancer	2.64e-06	2.11e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PTGS2—breast cancer	2.62e-06	2.09e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PIK3CD—breast cancer	2.59e-06	2.07e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—IL6—breast cancer	2.57e-06	2.05e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—ALB—breast cancer	2.56e-06	2.04e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—PTEN—breast cancer	2.51e-06	2e-05	CbGpPWpGaD
Lumiracoxib—PTGS1—Metabolism—AKT1—breast cancer	2.5e-06	2e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—NOS3—breast cancer	2.45e-06	1.95e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—PIK3CA—breast cancer	2.43e-06	1.94e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Disease—AKT1—breast cancer	2.37e-06	1.89e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PTEN—breast cancer	2.28e-06	1.82e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PIK3CB—breast cancer	2.26e-06	1.8e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PTGS2—breast cancer	2.24e-06	1.79e-05	CbGpPWpGaD
Lumiracoxib—PTGS2—Metabolism—AKT1—breast cancer	1.99e-06	1.59e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PTEN—breast cancer	1.95e-06	1.56e-05	CbGpPWpGaD
Lumiracoxib—PTGS1—lymph node—breast cancer	1.95e-06	0.0149	CbGeAlD
Lumiracoxib—PTGS2—lymph node—breast cancer	1.86e-06	0.0143	CbGeAlD
Lumiracoxib—CYP2C19—Metabolism—PIK3CA—breast cancer	1.77e-06	1.41e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—PIK3CA—breast cancer	1.61e-06	1.29e-05	CbGpPWpGaD
Lumiracoxib—CYP2C19—Metabolism—AKT1—breast cancer	1.44e-06	1.15e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—PIK3CA—breast cancer	1.38e-06	1.1e-05	CbGpPWpGaD
Lumiracoxib—CYP2C9—Metabolism—AKT1—breast cancer	1.32e-06	1.05e-05	CbGpPWpGaD
Lumiracoxib—CYP1A2—Metabolism—AKT1—breast cancer	1.13e-06	8.98e-06	CbGpPWpGaD
